MDXG - MiMedx Group Inc. (MDXG) Q1 2024 Earnings Call Transcript
2024-04-30 21:33:08 ET
MiMedx Group, Inc. (MDXG)
Q1 2024 Earnings Conference Call
April 30, 2024, 04:30 PM ET
Company Participants
Matt Notarianni - Head of Investor Relations
Joe Capper - Chief Executive Officer
Doug Rice - Chief Financial Officer
Conference Call Participants
Chase Knickerbocker - Craig Hallum
Brooks O'Neil - Lake Street Capital Markets
Anthony Petrone - Mizuho
Carl Byrnes - Northland Capital Markets
Swayampakula Ramakanth - H.C. Wainwright
John Vandermosten - Zacks
Presentation
Operator
Good afternoon and thank you for standing by. Welcome to the MiMedx First Quarter 2024 Operating and Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host, Mr. Matt Notarianni, Head of Investor Relations for MiMedx. Thank you. You may now begin.
Matt Notarianni
Thank you, operator and good afternoon, everyone. Welcome to the MiMedx first quarter 2024 operating and financial results conference call. With me on today's call are Chief Executive Officer, Joe Capper and Chief Financial Officer, Doug Rice.
As part of today's webcast, we are simultaneously displaying slides that you can follow. You can access the slides from the Investor Relations website at mimedx.com. Joe will kick us off with some opening remarks and Doug will provide a summary of our operating highlights and financial results for the quarter, and then Joe will conclude with some additional updates. We will then be available for your questions.
Before we begin, I would like to remind you that our comments today will include forward-looking statements, including statements regarding future sales, EBITDA, free cash flow and cash balance growth, future margins and expenses, and expected market sizes for our products. These expectations are subject to risks and uncertainties, and actual results may differ materially from those anticipated due to many factors. Actual results and market sizes will depend on a number of factors, including competition, access to customers, the reimbursement environment, unforeseen circumstances and delays, and other factors. Additional factors that could impact outcomes and our results include those described in the Risk Factors section of our annual report on Form 10-K and our quarterly report on Form 10-Q, which we plan to file shortly.
Also, our comments today include non-GAAP financial measures, and we provide a reconciliation to GAAP measures in our press release, which is available on our website at www.mimedx.com,...
MiMedx Group, Inc. (MDXG) Q1 2024 Earnings Call Transcript